Vu1 (VUOC) 10-Q 12 Nov 13 2013 Q3 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	9 Months Ended
	Sep. 30, 2013	Nov. 12, 2013
Document and Entity Information:	'	'
Entity Registrant Name	'Vu1 CORP	'
Document Type	'10-Q	'
Document Period End Date	30-Sep-13	'
Amendment Flag	'false	'
Entity Central Index Key	'0000906448	'
Current Fiscal Year End Date	'--12-31	'
Entity Common Stock, Shares Outstanding	'	10,426,097
Entity Filer Category	'Smaller Reporting Company	'
Entity Current Reporting Status	'Yes	'
Entity Voluntary Filers	'No	'
Entity Well-known Seasoned Issuer	'No	'
Document Fiscal Year Focus	'2013	'
Document Fiscal Period Focus	'Q3	'

UNAUDITED_CONDENSED_CONSOLIDAT

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (USD $)	Sep. 30, 2013	Dec. 31, 2012
Current assets	'	'
Cash	$76,588	$328,188
Prepaid expenses	88,608	42,722
Total current assets	165,196	370,910
Non-current assets	'	'
Equipment, net of accumulated depreciation of $1,701 and $0	32,314	'
Loan costs	'	118,500
Total assets	197,510	489,410
LIABILITIES AND STOCKHOLDERS' EQUITY	'	'
Accounts payable	1,437,309	1,008,692
Accrued payroll	192,725	192,725
Loan payable	100,000	100,000
Convertible debentures, net of discount of $0 and $571,254, respectively	3,905,975	3,546,496
Convertible bridge loans	'	309,000
Liabilities of Sendio	555,454	555,454
Total current liabilities	6,191,463	5,712,367
Total liabilities	6,191,463	5,712,367
Stockholders' deficit	'	'
Preferred stock, $1.00 par value; 10,000,000 shares authorized; no shares issued and outstanding	'	'
Common stock, no par value; 90,000,000 shares authorized; 9,926,097 and 7,130,226 shares issued and outstanding, respectively	81,777,805	78,279,737
Accumulated deficit	-87,675,703	-83,406,639
Total Vu1 Corporation's stockholders' deficit	-5,897,898	-5,126,902
Non-controlling interest	-96,055	-96,055
Total stockholders' deficit	-5,993,953	-5,222,957
Total liabilities and stockholders' deficit	$197,510	$489,410

UNAUDITED_CONDENSED_CONSOLIDAT1

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS PARENTHETICAL (USD $)	Sep. 30, 2013	Dec. 31, 2012
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS PARENTHETICAL	'	'
Accumulated depreciation	$1,701	'
Discount associated with convertible debentures, current	'	$571,254
Preferred stock par value	$1	$1
Preferred stock shares authorized	10,000,000	10,000,000
Preferred stock shares issued	'	'
Preferred stock shares outstanding	'	'
Common stock par value	'	'
Common stock shares authorized	90,000,000	90,000,000
Common stock shares issued	9,926,097	7,130,226
Common stock shares outstanding	9,926,097	7,130,226

UNAUDITED_CONDENSED_CONSOLIDAT2

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Operating expenses	'	'	'	'
Research and development	$185,740	$203,556	$447,347	$510,444
General and administrative	280,500	347,025	1,387,984	1,170,277
Marketing	124,518	228,329	278,658	679,172
Total operating expenses	590,758	778,910	2,113,989	2,359,893
Loss from operations	-590,758	-778,910	-2,113,989	-2,359,893
Other income (expense)	'	'	'	'
Interest income	'	'	'	19
Interest expense	-151,612	-334,495	-1,040,311	-960,226
Loss on conversion of debt	'	-60,774	-1,114,764	-353,161
Derivative valuation gain	'	'	'	592,783
Total other income (expense)	-151,612	-395,269	-2,155,075	-720,585
Loss before provision for income taxes	-742,370	-1,174,179	-4,269,064	-3,080,478
Provision for income taxes	'	'	'	'
Net loss	-742,370	-1,174,179	-4,269,064	-3,080,478
Other comprehensive (loss) income:	'	'	'	'
Foreign currency translation adjustments	'	'	'	25,374
Comprehensive loss	($742,370)	($1,174,179)	($4,269,064)	($3,055,104)
Basic Loss per share	($0.08)	($0.20)	($0.48)	($0.52)
Diluted Loss per share	($0.08)	($0.20)	($0.48)	($0.52)
Basic Weighted average shares outstanding	9,591,649	5,987,970	8,858,137	5,869,930
Diluted Weighted average shares outstanding	9,591,649	5,987,970	8,858,137	5,869,930

UNAUDITED_CONDENSED_CONSOLIDAT3

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
Cash Flows From Operating Activities	'	'
Net loss	($4,269,064)	($3,080,478)
Adjustments to reconcile net loss to net cash flows from operating activities:	'	'
Depreciation	1,701	915
Share-based compensation	928,140	411,651
Amortization of discount on long-term convertible notes	571,254	752,129
Amortization of loan costs	118,500	165,337
Amortization of prepaid interest	25,000	0
Derivative valuation gain	'	-592,783
Loss on conversion of debt	1,114,764	353,161
Changes in assets and liabilities:	'	'
Change in accounts receivable	'	3,616
Change in prepaid expenses	-70,886	-14,983
Change in accounts payable	497,778	498,907
Change in accrued payroll	'	90,898
Net cash flows from operating activities	-1,082,813	-1,411,630
Cash flows from investing activities:	'	'
Purchase of equipment	-34,015	'
Net cash flows from investing activities	-34,015	'
Cash flows from financing activities:	'	'
Net proceeds from sales of common stock and warrants	853,465	1,400,768
Payment on convertible debenture	-88,237	'
Proceeds from loan payable	100,000	'
Net cash flows from financing activities	865,228	1,400,768
Effect of exchange rate changes on cash	'	208
Net change in cash	-251,600	-10,654
Cash, beginning of period	328,188	10,992
Cash, end of period	76,588	338
Supplemental Cash Flow Information:	'	'
Cash paid for interest	'	'
Supplemental Noncash Investing and Financing Activities:	'	'
Conversion of bridge loan and interest to stock and warrants	368,162	193,431
Conversion of debenture for stock	123,538	'
Issuance of common stock and warrants for note payable and interest	110,000	'
Issuance of common stock and warrants for accounts payable	'	$42,000

Note_1_Business_and_Organizati

Note 1 - Business and Organization	9 Months Ended
	Sep. 30, 2013
Notes	'
Note 1 - Business and Organization	'
	NOTE 1 - BUSINESS AND ORGANIZATION
	General
	All references in these consolidated financial statements to “we,” “us,” “our,” and the “Company” are to Vu1 Corporation, Sendio, s.r.o., our Czech subsidiary, and Telisar Corporation, our inactive subsidiary unless otherwise noted or indicated by its context.
	We are focused on developing, manufacturing and selling a line of mercury free, energy efficient light bulbs based on our proprietary light-emitting technology. For the past several years, we have primarily focused on research and development efforts for our technology products and the related manufacturing processes.
	We have one inactive subsidiary, Telisar Corporation, a California corporation and 66.67% majority-owned subsidiary.

Note_2_Basis_of_Presentation_a

Note 2 - Basis of Presentation and Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2013
Notes	'
Note 2 - Basis of Presentation and Summary of Significant Accounting Policies	'
	NOTE 2 – BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
	Basis of Presentation
	The consolidated unaudited financial statements included in this Form 10-Q have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q. Accordingly, these financial statements do not include all of the disclosures required by U.S. generally accepted accounting principles for complete financial statements.  These consolidated unaudited interim financial statements should be read in conjunction with the audited financial statements for the fiscal year ended December 31, 2012 in our Annual Report on Form 10-K.  The financial information furnished herein reflects all adjustments consisting of normal, recurring adjustments which, in the opinion of management, are necessary for a fair presentation of our financial position, the results of operations and cash flows for the periods presented.  Operating results for the quarterly period ended September 30, 2013 are not necessarily indicative of results for future quarters or periods in the fiscal year ending December 31, 2013.
	Principles of Consolidation
	The consolidated financial statements include the accounts of the Company and all of its wholly-owned and controlled subsidiaries. All significant intercompany transactions and balances have been eliminated in consolidation.
	Use of Estimates
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
	Cash and Cash Equivalents
	For purposes of the statements of cash flows, we consider all investments purchased with original maturities of three months or less to be cash equivalents. At September 30, 2013 and December 31, 2012 we had $0 and $78,188 of cash in excess of federal insurance limits, respectively.
	Income Taxes
	We recognize the amount of income taxes payable or refundable for the current year and recognize deferred tax assets and liabilities for the future tax consequences attributable to differences between the financial statement amounts of certain assets and liabilities and their respective tax bases. Deferred tax assets and deferred tax liabilities are measured using enacted tax rates expected to apply to taxable income in the years those temporary differences are expected to be recovered or settled. A valuation allowance is required when it is more likely than not that we will not be able to realize all or a portion of our deferred tax assets. The fiscal years 2010 to 2012 remain open to examination to U.S. Federal authorities and other jurisdictions in the U.S. where we operate.
	We recognize the impact of an uncertain tax position in the consolidated financial statements of a tax position, if that position is more likely than not of being sustained upon examination, based on the technical merits of the position.  Recognized income tax positions are measured at the largest amount that is greater than 50% likely of being realized. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs. The Company has elected to classify interest and penalties related to unrecognized tax benefits, if and when required, as part of income tax expense in the consolidated statements of operations.
	Loan Costs
	Loan costs are amortized to interest expense using the straight line method, which approximates the effective interest method, over the life of the related loan.
	Equipment
	Equipment is comprised of equipment used in the manufacturing process and related testing and development of our lighting products and is stated at cost. We provide for depreciation using the straight-line method over the estimated useful lives of three to fifteen years. Expenditures for maintenance and repairs are charged to operations as incurred while renewals and betterments are capitalized. Gains or losses on the sale of equipment are reflected in the statements of operations.
	Long-Lived Assets
	Long-lived assets are reviewed for impairment when events or changes in circumstances indicate that the carrying amount may not be recoverable. Recoverability of assets to be held and used is measured by comparison of the carrying amount of an asset to future net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount that the carrying amount of the assets exceeds the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount or fair value less costs to sell.
	Fair Value Measurements
	ASC 820 “Fair Value Measurements” defines fair value, establishes a framework for measuring fair value in generally accepted accounting principles, and expands disclosures about fair value measurements. This hierarchy prioritizes the inputs into three broad levels. Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2 inputs are quoted prices for similar assets and liabilities in active markets or inputs that are observable for the asset or liability, either directly or indirectly through market corroboration, for substantially the full term of the financial instrument. Level 3 inputs are unobservable inputs based on our own assumptions used to measure assets and liabilities at fair value. A financial asset or liability’s classification within the hierarchy is determined based on the lowest level input that is significant to the fair value measurement. Significant fair value measurements resulted from the application of ASC 815 to our convertible promissory note and ASC 718-10 for our share-based payment arrangements.  We used level 3 inputs to measure fair value of these instruments.
	Fair Value of Financial Instruments
	Financial instruments consist of a loan payable and convertible debentures.  It is not practical to determine the fair value of the Company's financial instruments due to the current terms and embedded financial instruments.
	Non-Controlling Interest
	Non-controlling interest represents the equity of the 33.3% non-controlling shareholders of Telisar Corporation.  The subsidiary had no operations for all periods presented.
	Revenue Recognition
	Revenues are recognized when (a) persuasive evidence of an arrangement exists, (b) delivery has occurred and no significant obligations remain, (c) the fee is fixed or determinable and (d) collection is determined to be probable.
	Research and Development Costs
	For financial reporting purposes, all costs of research and development activities performed internally or on a contract basis are expensed as incurred. For the nine months ended September 30, 2013 and 2012, research and development expenses were comprised primarily of technical consulting expenses, travel, materials and operational costs related to the development of the production line.
	Share-Based Payments
	We account for share-based compensation expense to reflect the fair value of share-based awards measured at the grant date.  This expense is recognized over the requisite service period and is adjusted each period for anticipated forfeitures. We estimate the fair value of each share-based award on the date of grant using the Black-Scholes option valuation model. The Black-Scholes option valuation model incorporates assumptions as to stock price volatility, the expected life of options, a risk-free interest rate and dividend yield.
	Loss Per Share
	We calculate basic loss per share by dividing loss available to common stockholders by the weighted-average number of shares of common stock outstanding, excluding unvested stock. Diluted loss per share is computed similar to basic loss per share except that the denominator is increased to include the number of additional shares of common stock that would have been outstanding if the potential common shares, including unvested stock, had been issued and if the additional common shares were dilutive.
	The following potentially dilutive shares of common stock are excluded from the computation of diluted net loss per share for all periods presented because the effect is anti-dilutive:
		Three months ended September 30,		Nine months ended September 30,
		2013	2012	2013	2012
	Warrants	4,122,228	1,366,108	4,122,228	1,366,108
	Convertible debt	1,152,223	374,346	1,152,223	374,346
	Stock options	571,338	591,181	571,338	591,181
	Unvested stock	275,989	168,500	275,989	168,500
	Total potentially dilutive securities	6,121,778	2,500,135	6,121,778	2,500,135

Note_3_Going_Concern_Matters

Note 3 - Going Concern Matters	9 Months Ended
	Sep. 30, 2013
Notes	'
Note 3 - Going Concern Matters	'
	NOTE 3 - GOING CONCERN MATTERS
	The accompanying financial statements have been prepared in conformity with generally accepted accounting principles which contemplate our continuation as a going concern. During the nine months ended September 30, 2013 we had no revenues, incurred a net loss of $4.27 million, (4,269,064) and had negative cash flows from operations of $1.1 million (1,082,813). In addition, we had an accumulated deficit of $87.7 million (87,675,703) at September 30, 2013. These factors raise substantial doubt about our ability to continue as a going concern.
	Recovery of our assets is dependent upon future events, the outcome of which is indeterminable. Our attainment of profitable operations is dependent upon our obtaining adequate debt or equity financing, developing products for commercial sale, and achieving a level of sales adequate to support our cost structure. The financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or amounts and classification of liabilities that might be necessary should we be unable to continue in existence.
	Our efforts to raise additional funds will continue during fiscal 2013 and into 2014 to fund our planned operations and research and development activities, through one or more debt or equity financings.  Subsequent to September 30, 2013, we raised gross proceeds of $500,000 in a private placement of our common stock and warrants to accredited investors.  See Note 10.

Note_4_Commitments_and_Conting

Note 4 - Commitments and Contingencies	9 Months Ended
	Sep. 30, 2013
Notes	'
Note 4 - Commitments and Contingencies	'
	NOTE 4 - COMMITMENTS AND CONTINGENCIES
	Lease Agreement
	On December 18, 2012 we entered into a 6 month lease for office space in New York, New York.  Monthly rental payments are $2,035.  In June, 2013 this was extended to December 31, 2013 on the same terms.
	Total rent expense was $18,542 and $8,782 for the nine months ended September 30, 2013 and 2012, respectively.
	Liabilities of Sendio
	In September 2007, we formed Sendio, s.r.o. (“Sendio”) in the Czech Republic as a wholly-owned subsidiary for the purpose of operating a research and development and pilot manufacturing facility. On February 13, 2012, Sendio filed a petition of insolvency with the Regional Court in Olomouc, Czech Republic.  In March, 2012 the court determined that Sendio was insolvent, and control of the legal entity passed to a court appointed trustee. The trustee will oversee the orderly sale of the assets and use any proceeds to satisfy the liabilities of Sendio.  These liabilities have been recorded as a current liability on our balance sheet as of September 30, 2013 under the caption “Liabilities of Sendio”.

Note_5_Convertible_Debentures

Note 5 - Convertible Debentures	9 Months Ended
	Sep. 30, 2013
Notes	'
Note 5 - Convertible Debentures	'
	NOTE 5 – CONVERTIBLE DEBENTURES
	On June 22, 2011, pursuant to a Securities Purchase Agreement, dated as of June 16, 2011, with several institutional investors, we completed a private placement of our original issue discount convertible debentures (referred to as the convertible debentures), receiving gross proceeds of $3,500,000.  Each convertible debenture was issued at a price equal to 85% of its principal amount.  The convertible debentures mature two years after the date of their issuance and do not bear regularly scheduled interest.  Investors may convert their convertible debentures into shares of our common stock at any time and from time to time on or before the maturity date, at a conversion price of $11.00 per share.
	The convertible debentures will mandatorily convert at our option into shares of our common stock at the conversion price, if the closing bid price for the common stock exceeds $30.00 per share for a period of 10 consecutive trading days, provided that such underlying shares have been fully registered for resale with the U.S. Securities and Exchange Commission (SEC).
	The convertible debentures are unsecured, general obligations of our company, and rank pari passu with our other unsecured and unsubordinated liabilities.  The convertible debentures are not redeemable or subject to voluntary prepayment by us prior to maturity.  The convertible debentures are identical for all of the investors except for principal amount.
	The investors agreed not to convert their convertible debentures or exercise their warrants (as discussed below), and we will not be permitted to require a mandatory conversion, to the extent such conversion, exercise or issuance would result in beneficial ownership of more than 4.99% of our outstanding shares at such time.
	Events of default under the convertible debentures include:
	•              failure to pay principal or any liquidated damages on any convertible debenture when due;
	•              failure to perform other covenants under the convertible debentures that is not cured five trading days after notice by holders;
	•              default under the other financing documents, subject to any grace or cure period provided in the applicable agreement, document or instrument;
	•              certain events of bankruptcy or insolvency of our company or any significant subsidiary.  The lender has waived this event of default with respect to the insolvency of Sendio;
	•              any default by our company or any subsidiary under any instrument in excess of $150,000 that results in such obligation becoming due and payable prior to maturity;
	•              we become party to a change of control transaction, or dispose of greater than 50% of our assets; and
	•              failure to deliver common stock certificates to a holder prior to the tenth trading day after a convertible debenture conversion date.
	Upon an event of default, the outstanding principal amount of the convertible debentures, plus a default premium, shall become immediately due and payable to the holders of the convertible debentures.
	The convertible debentures contain various covenants that limit our ability to:
	•              incur additional indebtedness, other than permitted indebtedness as defined in the convertible debenture;
	•              incur specified liens, other than permitted liens as defined in the convertible debenture;
	•              amend our certificate of incorporation or by-laws in a material adverse manner to the holders; and
	•              repay or repurchase more than a de minimus number of shares of our common stock.
	As part of the financing, we also agreed not to undertake a reverse or forward stock split or reclassification of our common stock until the one-year anniversary of the closing date, except with the consent of a majority in interest of the holders or in connection with an up-listing of our common stock onto a trading market other than the OTC Bulletin Board.
	We also issued to the investors five-year warrants to purchase up to 187,175 shares of our common stock at an exercise price of $13.00 per share.  The warrants may be exercised on a cashless basis at any time after the earlier of (i) one year after the date of their issuance or (ii) the completion of the applicable holding period required by Rule 144 in the event the underlying shares have not been fully registered for resale with the SEC.  The warrants are not callable.  Neither the warrants nor the convertible debentures contain a provision for anti-dilution adjustments in the event of a subsequent equity financing at a price less than the respective warrant exercise price or convertible debenture conversion price.
	Pursuant to a Registration Rights Agreement, dated as of June 16, 2011, with the investors, we agreed to file a shelf registration statement covering the resale of the shares of common stock issuable upon the conversion of the convertible debentures and exercise of the warrants within 30 days after the closing, use our best efforts to cause the shelf registration statement to be declared effective within 90 days after the closing (or 120 days in the event of a “full review” by the SEC), and keep the shelf registration statement effective until the underlying shares have been sold or may be sold without volume or manner of sale restrictions pursuant to Rule 144 under the Securities Act of 1933 and if we are unable to comply with this covenant, we will be required to pay liquidated damages to the investors in the amount of 1.5% of the investors’ purchase price per month during such non-compliance (capped at a maximum of 10% of the purchase price), with such liquidated damages payable in cash.  We filed the registration statement on July 15, 2011 and it was declared effective on July 26, 2011.  We evaluated any liability under the registration rights agreement at September 30, 2013 and determined no accrual was necessary.
	Effective June 22, 2013, the Company entered into a letter agreement with holders of $2,553,000 in principal amount of the Debentures.  The maturity date of these Debentures was extended to June 23, 2014 and the conversion price was reduced from $11.00 to $2.50 per share.  In addition, these Debentures will bear interest at an annual rate of 10% per annum, payable in equal installments on the six month and one year anniversary of the letter agreement.
	Also, effective June 22, 2013, the Company entered into a separate letter agreement with the holder of approximately $123,538 in principal amount of the Debentures to reduce the conversion price of these Debentures from $11.00 to $1.22 per share.  This holder then converted the principal amount of their Debentures into 101,260 shares of common stock.
	We evaluated the amended debentures above to determine if there was an extinguishment of debt or beneficial conversion feature arising as a result of the amendments and determined there was none.
	On June 22, 2013, the Company did not make the required payment on the remaining $1,441,213 in principal amount of the Debentures described above, which constitutes an event of default under the terms of the remaining original Debentures.  As a result, the Company recorded a penalty of 10% of the principal amount of $144,121 as interest expense on the accompanying statement of operations for the nine months ended September 30, 2013. The Company is also liable for all other amounts, costs, expenses and liquidated damages due in respect of those Debentures.  Additionally, the remaining original Debentures will bear default interest at a rate of 18% per annum. As a result of the Debentures being past due, the investors may at any time exercise their remedies under the terms of the Debentures.
	The carrying value at September 30, 2013 and December 31, 2012 of the convertible debentures is as follows:
		30-Sep-13	31-Dec-12
	Debentures Due June 22, 2013, in default at June 30, 2013, interest at 18%	$               1,352,975	$               4,117,750
	Debentures Due June 23, 2014, interest at 10%	2,553,000	-
	Original issue discount	-	(155,443)
		3,905,975	3,962,307
	Beneficial conversion feature and warrant allocation	-	(415,811)
	Carrying value	$               3,905,975	$               3,546,496
	The original issue discount of the convertible debentures is being amortized over their two-year life using the effective interest method.
	Interest expense related to the convertible debentures is as follows:
		Three months ended September 30,		Nine months ended September 30,
		2013	2012	2013	2012
	Amortization of original issue discount	$                    -	$                    78,588	$                  155,443	$                  229,416
	Amortization of beneficial conversion feature and warrant allocation	-	187,242	415,811	522,713
	Amortization of loan costs	-	55,515	104,392	165,337
	Penalty interest	-	-	144,121	-
	Stated interest payable in cash	124,012	-	135,294	-
		$                  124,012	$                  321,345	$                  955,061	$                  917,466

Note_6_Convertible_Bridge_Loan

Note 6 - Convertible Bridge Loans	9 Months Ended
	Sep. 30, 2013
Notes	'
Note 6 - Convertible Bridge Loans	'
	NOTE 6 – CONVERTIBLE BRIDGE LOANS
	In October and November 2011, we received $475,000 in gross proceeds from six existing stockholders in an interim convertible bridge loan financing involving the issuance of 12% convertible promissory notes and warrants to purchase common stock.  Included in the proceeds was $50,000 received from Mark W. Weber, a member of our board of directors.  Under the notes, the loans are due upon the earlier of (a) the closing of financing pursuant to which shares of common stock or other equity securities are issued by us for aggregate consideration of not less than $5,000,000, through the (i) conversion of the note, including accrued interest, or (ii) at the lender’s option, repayment of the note, or (b) in any event, two years after the issuance of the note.  The number of shares of common stock issuable upon conversion of the note will be based on a conversion price equal to a 15% discount to the price obtained in any round of equity financing.  In the event we fail to repay the promissory notes on or before November 30, 2011, the note’s interest rate will be increased to 15% per annum.  We did not repay the promissory notes prior to that date, and the interest rate was increased to 15% per annum.  Total interest expense related to the loans for the nine months ended September 30, 2013 and 2012 was $7,027 and $42,760, respectively.
	In addition to interest on the promissory note, each note holder is entitled to receive a warrant to purchase the number of shares of common stock determined by dividing 115% of the principal amount of the note by the price at which our common stock is sold in any round of equity financing not less than $5,000,000, times 100%.  The warrants will be exercisable at any time, commencing 90 days after the closing of the round of financing, and from time to time for a period of three years after the issuance date, at an exercise price of $11.00 per share (subject to appropriate adjustment in the event of any subsequent stock split or similar transaction).
	During February, 2013 three of the convertible bridge loans totaling $368,162 (including accrued interest and loan fees of $68,162) were converted into 368,162 shares of our restricted common stock, three year warrants to purchase 368,162 shares of our common stock at an exercise price of $1.50 per share and three year warrants to purchase 98,571 shares of our common stock at an exercise price of $11.00 per share.  The fair value of the common stock was $662,690 based on the market prices of our common stock on the date of conversion of $1.80 per share.  The fair value of the three year warrants to purchase 368,162 shares of our common stock at an exercise price of $1.50 per share was $633,121 and fair value of the three year warrants to purchase 98,571 shares of our common stock at an exercise price of $11.00 per share was $158,094.  We recognized a loss on debt conversion for the nine months ended September 30, 2013 in the amount of $1,085,744.
	The fair value of the warrants issued upon the conversion was computed using the Black Scholes Option Pricing model using the following assumptions – expected life – 3 years, risk free interest rate – 0.82%, volatility – 227.1%, and an expected dividend rate of 0%.

Note_7_Loans_Payable

Note 7 - Loans Payable	9 Months Ended
	Sep. 30, 2013
Notes	'
Note 7 - Loans Payable	'
	NOTE 7 – LOANS PAYABLE
	On December 20, 2012, we received gross proceeds of $100,000 pursuant to the terms of a Loan Agreement dated December 20, 2012.  The loan is secured by a Deed of Assignment for certain inventory and all proceeds from the sale of the inventory.  The loan is payable on June 23, 2013, six months from the date of the agreement.  We prepaid interest of $25,000 for the term of the loan and $15,000 for loan costs, which are being amortized over the life of the note.  We recognized $27,600 and $0 of interest expense and $54,114 and $0 for the three and nine months ended September 30, 2013 and 2012, respectively.  On June 23, 2013 we did not repay the loan and it is in default.  As a result of the default, the interest rate on the loan is 109.5% per annum from the date of default.
	Total principal payments for future years for the Convertible Debentures described in Note 5 and the Loan Payable are as follows as of September 30, 2013:
		30-Sep-13
	2013	4,005,975
		$               4,005,975
	On May 16, 2013 we received gross proceeds of $100,000 pursuant to a Loan Agreement as of that date.  The term of the loan was for 30 days.  Total interest for the 30 day term was $10,000, which was recognized as interest expense for the nine months ended September 30, 2013.  On June 18, 2013 the holder of the loan converted $110,000 of principal and interest in our unit private placement as further described in Note 8 at a conversion price of $1.50 per share into 73,333 shares of common stock and three-year warrants to purchase common stock at an exercise price of $2.00 per share.  The fair value of the common stock was $95,333 based on the market prices of our common stock on the date of conversion of $1.30 per share.  The fair value of the three year warrants to purchase 73,333 shares of our common stock at an exercise price of $2.00 per share was $43,687. We recognized a loss on debt conversion for the nine months ended September 30, 2013 in the amount of $29,020.
	The fair value of the warrants issued upon the conversion was computed using the Black Scholes Option Pricing model using the following assumptions – expected life – 3 years, risk free interest rate – 0.42%, volatility – 91.4%, and an expected dividend rate of 0%.

Note_8_Stockholders_Equity

Note 8 - Stockholders' Equity	9 Months Ended
	Sep. 30, 2013
Notes	'
Note 8 - Stockholders' Equity	'
	NOTE 8 – STOCKHOLDERS’ EQUITY
	Preferred Stock
	Our Amended and Restated Articles of Incorporation allow us to issue up to 10,000,000 shares of preferred stock without further stockholder approval and upon such terms and conditions, and having such rights, preferences, privileges, and restrictions as the Board of Directors may determine.  No preferred shares are currently issued and outstanding.
	Common Stock
	2012 Unit Offering Amendment
	During 2012, we issued a total of 474,632 shares of our restricted common stock and three-year warrants to purchase 474,632 shares of our common stock at an exercise price of $2.00 per share pursuant to a private placement to accredited investors at a price of $3.50 per unit. Each unit was comprised of one share of common stock and one warrant.  On January 25, 2013 we amended the terms of the private placement, reducing the purchase price of the unit to $1.00 and reducing the exercise price of the warrant to $1.50 per share.  As a result of the amendment, the Company issued an additional 1,186,567 shares of common stock to those investors and increased the number of shares reserved for issuance upon the exercise of the warrants by 1,186,567. The issuance of the shares under the amendment was considered non-compensatory; therefore, there was no effect on the results of operations. The effect of the issuance was a reallocation of the original gross proceeds among additional paid-in capital accounts attributable to the shares and warrants, based on the relative fair values of the instruments delivered in total, including those issued under the amended terms. As a result of this reduction in price and change in the number of issued shares, the allocation of the net proceeds of $1,425,768 would have resulted in $587,989 being allocated to the warrants and the balance of the proceeds of $837,779 would have been allocated to the common stock.
	2013 Unit Offerings
	On January 25, 2013 we completed a private placement to accredited investors of 105,000 restricted shares of our common stock, at a purchase price of $1.00 per share, for gross proceeds of $105,000.  As part of the private placement, the investors were issued three-year warrants to purchase 105,000 shares of our common stock, at an exercise price of $1.50 per share.
	The net proceeds were allocated based on the relative fair values of the common stock and the warrants on the dates of issuance.  The amount allocated to the fair value of the warrants was $52,363 and the balance of the proceeds of $52,637 was allocated to the common stock.
	The fair value of the warrants issued in our unit private placement was calculated using the Black-Scholes option valuation model with the following assumptions – expected life – 3 years, risk free interest rate – 0.42%, volatility – 346.4%, and an expected dividend rate of 0%.
	From April 9 to September 30, 2013 we raised gross proceeds of $871,000 in a unit private placement to accredited investors at a price of $1.50 per unit.  Each unit is comprised of one share of common stock and one three-year warrant to purchase common stock at an exercise price of $2.00 per share.  Included in the proceeds is $110,000 of principal and interest which was converted into the unit offering as described in Note 7.  Also included is $10,000 received from a member of our board of directors.  We issued an aggregate of 580,667 shares of common stock and warrants to purchase 580,667 shares of common stock at an exercise price of $2.00 per share.
	The net proceeds of $761,000 were allocated based on the relative fair values of the common stock and the warrants on the dates of issuance.  The amount allocated to the fair value of the warrants was $256,836 and the balance of the proceeds of $504,164 was allocated to the common stock.  The fair value of the warrants issued was computed using the Black Scholes Option Pricing model using the following assumptions – expected life – 3 years, risk free interest rate – 0.34% to 0.65%, volatility – 91.4% to 150.3%, and an expected dividend rate of 0%.
	Issuances of common stock
	During the nine months ended September 30, 2013 we issued 685,667 shares of common stock in our unit offerings described above and 368,162 shares of common stock upon the conversion of three of the convertible bridge loans as described in Note 6.
	From January 1 to September 30, 2013 we issued 48,842 shares of common stock with a fair value of $75,000 to SAM Advisors, LLC. The issuances were based on the closing market prices as of the date of issuance pursuant to our agreement to convert their $12,500 monthly consulting fee to stock at the closing market price on the last business day of each month. SAM Advisors, LLC is an entity controlled by William B. Smith, our chairman and chief executive officer.  Effective July 1, 2013 Mr. Smith receives this amount in cash.
	From January 1 to September 30, 2013 we issued 6,143 shares of common stock with a fair value of $11,250 to Charles Hunt, a member of our board of directors. The issuances were based in the closing market prices as of the date of issuance pursuant to our agreement to convert $3,750 of his monthly consulting fee to stock at the closing market price on the last business day of each month.
	Stock and Stock Options issued and exercised pursuant to the 2007 Stock Incentive Plan
	On August 26, 2013 the board of directors increased the number of shares authorized for issuance under the 2007 Stock Incentive Plan by 1,500,000 shares to a total of 2,500,000 shares.
	Stock issuances
	On February 20, 2013 we issued 80,000 shares of restricted stock from the 2007 Stock Incentive Plan to two board members and an officer for services vesting on the date of grant.  The shares had a fair value of $128,800 based on the closing market price of our common stock on that date of $1.61 per share.
	On June 15, 2013 we issued 19,231 shares of restricted common stock to a consultant for services vesting in equal monthly installments through the one year anniversary date of service.  The shares had a fair value of $25,000 based on the closing market price of our common stock of $1.30 as of that date.
	On August 26, 2013 we issued 300,000 shares of restricted common stock to our non-executive board members and an officer for services vesting ratably through June 1, 2014.  The shares had a fair value of $360,000 based in the closing market price of $1.20 as of that date.
	We recognized a total of $57,302, $132,665, $419,617 and $172,780 of compensation expense related to restricted stock issuances as general and administrative and research and development expenses for the three and nine months ended September 30, 2013 and 2012, respectively.
	At September 30, 2013 there are 275,989 shares of unvested restricted stock representing $332,547 of unrecognized compensation expense of which we anticipate $124,960 to be recognized through December 31, 2013 and $207,587 will be recognized in the first half of 2014.
	Stock Option issuances
	On February 20, 2013 we issued ten-year, fully vested options to purchase 42,600 shares of common stock from the 2007 Stock Incentive Plan at an exercise price of $1.61 per share to two board members and an officer for services.  The fair value of the options granted of $68,741 was calculated using the Black-Scholes option valuation model with the following assumptions – expected life –10 years, risk free interest rate –2.02%, volatility –246.2%, and an expected dividend rate of 0%.
	On March 11, 2013 we issued five-year options to purchase 250,000 shares of common stock at an exercise price of $1.70 per share to William B. Smith, our Chairman and Chief Executive Officer.  A total of 83,334 options vested immediately, with an additional 83,333 shares vesting on the six month and twelve month anniversary of the options.  In addition, certain performance based criteria provide for the potential acceleration of the vesting schedule.  The fair value of the options granted of $410,540 was calculated using the Black-Scholes option valuation model with the following assumptions – expected life – 5 years, risk free interest rate – 0.9%, volatility – 188.8%, and an expected dividend rate of 0%.
	We recognized compensation expense of $87,429, $1,933, $422,062 and $132,416 related to the vested portion of stock options based on their estimated grant date fair value as marketing expense, research and development expense or general and administrative expense based on the specific recipient of the award for the three and nine months ended September 30, 2013 and 2012, respectively.
	At September 30, 2013, we have unrecognized compensation expense related to stock options of $60,935, of which we anticipate $34,212 will be recognized through December 31, 2013 and $26,724 will be recognized in 2014.
	During the nine months ended September 30, 2013 options to purchase 30,266 shares of common stock at a weighted average exercise price of $14.32 expired unexercised.
	Warrants
	As a result of the amendment of our 2012 Unit Offering as described above, the Company issued warrants to purchase an additional 1,186,567 shares of common stock at an exercise price of $1.50 per share to the investors in the offering.
	During the nine months ended September 30, 2013 we issued three year warrants to purchase 105,000 shares of common stock at an exercise price of $1.50 per share in our unit offering described above.
	During the nine months ended September 30, 2013 we issued three year warrants to purchase 580,667 shares of common stock at an exercise price of $2.00 per share in our unit offering described above.
	Also during the nine months ended September 30, 2013 we issued three year warrants to purchase 368,162 shares of our common stock at an exercise price of $1.50 per share and three year warrants to purchase 98,571 shares of our common stock at an exercise price of $11.00 per share to three investors upon the conversion of convertible bridge notes as described in Note 6.
	During the nine months ended September 30, 2013 warrants to purchase a total of 230,858 shares of common stock with a weighted average exercise price of $15.31 expired unexercised.
	A summary of our outstanding warrants at September 30, 2013 is as follows:
			Weighted-Average
	Exercise	Warrants	Remaining Contractual	Number
	Price	Outstanding	Life (Years)	Exercisable
	$1.50	2,909,360	1.9	2,909,360
	$2.00	580,667	2.7	580,667
	$9.00	262,750	2.4	262,750
	$11.00	156,071	2.1	156,071
	$13.00	213,380	2.7	213,380
		4,122,228	2.3	4,122,228

Note_9_Related_Party_Transacti

Note 9 - Related Party Transactions	9 Months Ended
	Sep. 30, 2013
Notes	'
Note 9 - Related Party Transactions	'
	NOTE 9 – RELATED PARTY TRANSACTIONS
	From January 1 to September 30, 2013 we issued 48,842 shares of common stock with a fair value of $75,000 to SAM Advisors, LLC. The issuances were based on the closing market prices as of the date of issuance pursuant to our agreement to convert their $12,500 monthly consulting fee to stock at the closing market price on the last business day of each month. SAM Advisors, Inc. is an entity controlled by William B. Smith, our chairman and chief executive officer.
	From January 1 to September 30, 2013 we issued 6,143 shares of common stock with a fair value of $11,250 to Charles Hunt, a member of our board of directors. The issuances were based in the closing market prices as of the date of issuance pursuant to our agreement to convert $3,750 of his monthly consulting fee to stock at the closing market price on the last business day of each month.

Note_10_Subsequent_Events

Note 10 - Subsequent Events	9 Months Ended
	Sep. 30, 2013
Notes	'
Note 10 - Subsequent Events	'
	NOTE 10 – SUBSEQUENT EVENTS
	Subsequent to September 30, 2013 we received gross proceeds of $500,000 from accredited investors at a price of $1.00 per unit and issued 500,000 shares of common stock and two-year warrants to purchase 500,000 shares of common stock at an exercise price of $1.25 per share.

Note_2_Basis_of_Presentation_a1

Note 2 - Basis of Presentation and Summary of Significant Accounting Policies: Basis of Presentation (Policies)	9 Months Ended
	Sep. 30, 2013
Policies	'
Basis of Presentation	'
	Basis of Presentation
	The consolidated unaudited financial statements included in this Form 10-Q have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q. Accordingly, these financial statements do not include all of the disclosures required by U.S. generally accepted accounting principles for complete financial statements.  These consolidated unaudited interim financial statements should be read in conjunction with the audited financial statements for the fiscal year ended December 31, 2012 in our Annual Report on Form 10-K.  The financial information furnished herein reflects all adjustments consisting of normal, recurring adjustments which, in the opinion of management, are necessary for a fair presentation of our financial position, the results of operations and cash flows for the periods presented.  Operating results for the quarterly period ended September 30, 2013 are not necessarily indicative of results for future quarters or periods in the fiscal year ending December 31, 2013.

Note_2_Basis_of_Presentation_a2

Note 2 - Basis of Presentation and Summary of Significant Accounting Policies: Principles of Consolidation (Policies)	9 Months Ended
	Sep. 30, 2013
Policies	'
Principles of Consolidation	'
	Principles of Consolidation
	The consolidated financial statements include the accounts of the Company and all of its wholly-owned and controlled subsidiaries. All significant intercompany transactions and balances have been eliminated in consolidation.

Note_2_Basis_of_Presentation_a3

Note 2 - Basis of Presentation and Summary of Significant Accounting Policies: Use of Estimates (Policies)	9 Months Ended
	Sep. 30, 2013
Policies	'
Use of Estimates	'
	Use of Estimates
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Note_2_Basis_of_Presentation_a4

Note 2 - Basis of Presentation and Summary of Significant Accounting Policies: Cash and Cash Equivalents (Policies)	9 Months Ended
	Sep. 30, 2013
Policies	'
Cash and Cash Equivalents	'
	Cash and Cash Equivalents
	For purposes of the statements of cash flows, we consider all investments purchased with original maturities of three months or less to be cash equivalents. At September 30, 2013 and December 31, 2012 we had $0 and $78,188 of cash in excess of federal insurance limits, respectively.

Note_2_Basis_of_Presentation_a5

Note 2 - Basis of Presentation and Summary of Significant Accounting Policies: Income Taxes (Policies)	9 Months Ended
	Sep. 30, 2013
Policies	'
Income Taxes	'
	Income Taxes
	We recognize the amount of income taxes payable or refundable for the current year and recognize deferred tax assets and liabilities for the future tax consequences attributable to differences between the financial statement amounts of certain assets and liabilities and their respective tax bases. Deferred tax assets and deferred tax liabilities are measured using enacted tax rates expected to apply to taxable income in the years those temporary differences are expected to be recovered or settled. A valuation allowance is required when it is more likely than not that we will not be able to realize all or a portion of our deferred tax assets. The fiscal years 2010 to 2012 remain open to examination to U.S. Federal authorities and other jurisdictions in the U.S. where we operate.
	We recognize the impact of an uncertain tax position in the consolidated financial statements of a tax position, if that position is more likely than not of being sustained upon examination, based on the technical merits of the position.  Recognized income tax positions are measured at the largest amount that is greater than 50% likely of being realized. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs. The Company has elected to classify interest and penalties related to unrecognized tax benefits, if and when required, as part of income tax expense in the consolidated statements of operations.

Note_2_Basis_of_Presentation_a6

Note 2 - Basis of Presentation and Summary of Significant Accounting Policies: Loan Costs (Policies)	9 Months Ended
	Sep. 30, 2013
Policies	'
Loan Costs	'
	Loan Costs
	Loan costs are amortized to interest expense using the straight line method, which approximates the effective interest method, over the life of the related loan.

Note_2_Basis_of_Presentation_a7

Note 2 - Basis of Presentation and Summary of Significant Accounting Policies: Equipment (Policies)	9 Months Ended
	Sep. 30, 2013
Policies	'
Equipment	'
	Equipment
	Equipment is comprised of equipment used in the manufacturing process and related testing and development of our lighting products and is stated at cost. We provide for depreciation using the straight-line method over the estimated useful lives of three to fifteen years. Expenditures for maintenance and repairs are charged to operations as incurred while renewals and betterments are capitalized. Gains or losses on the sale of equipment are reflected in the statements of operations.

Note_2_Basis_of_Presentation_a8

Note 2 - Basis of Presentation and Summary of Significant Accounting Policies: Long-lived Assets (Policies)	9 Months Ended
	Sep. 30, 2013
Policies	'
Long-lived Assets	'
	Long-Lived Assets
	Long-lived assets are reviewed for impairment when events or changes in circumstances indicate that the carrying amount may not be recoverable. Recoverability of assets to be held and used is measured by comparison of the carrying amount of an asset to future net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount that the carrying amount of the assets exceeds the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount or fair value less costs to sell.

Note_2_Basis_of_Presentation_a9

Note 2 - Basis of Presentation and Summary of Significant Accounting Policies: Fair Value Measurements (Policies)	9 Months Ended
	Sep. 30, 2013
Policies	'
Fair Value Measurements	'
	Fair Value Measurements
	ASC 820 “Fair Value Measurements” defines fair value, establishes a framework for measuring fair value in generally accepted accounting principles, and expands disclosures about fair value measurements. This hierarchy prioritizes the inputs into three broad levels. Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2 inputs are quoted prices for similar assets and liabilities in active markets or inputs that are observable for the asset or liability, either directly or indirectly through market corroboration, for substantially the full term of the financial instrument. Level 3 inputs are unobservable inputs based on our own assumptions used to measure assets and liabilities at fair value. A financial asset or liability’s classification within the hierarchy is determined based on the lowest level input that is significant to the fair value measurement. Significant fair value measurements resulted from the application of ASC 815 to our convertible promissory note and ASC 718-10 for our share-based payment arrangements.  We used level 3 inputs to measure fair value of these instruments.

Recovered_Sheet1

Note 2 - Basis of Presentation and Summary of Significant Accounting Policies: Fair Value of Financial Instruments (Policies)	9 Months Ended
	Sep. 30, 2013
Policies	'
Fair Value of Financial Instruments	'
	Fair Value of Financial Instruments
	Financial instruments consist of a loan payable and convertible debentures.  It is not practical to determine the fair value of the Company's financial instruments due to the current terms and embedded financial instruments.

Recovered_Sheet2

Note 2 - Basis of Presentation and Summary of Significant Accounting Policies: Non-controlling Interest (Policies)	9 Months Ended
	Sep. 30, 2013
Policies	'
Non-controlling Interest	'
	Non-Controlling Interest
	Non-controlling interest represents the equity of the 33.3% non-controlling shareholders of Telisar Corporation.  The subsidiary had no operations for all periods presented.

Recovered_Sheet3

Note 2 - Basis of Presentation and Summary of Significant Accounting Policies: Revenue Recognition (Policies)	9 Months Ended
	Sep. 30, 2013
Policies	'
Revenue Recognition	'
	Revenue Recognition
	Revenues are recognized when (a) persuasive evidence of an arrangement exists, (b) delivery has occurred and no significant obligations remain, (c) the fee is fixed or determinable and (d) collection is determined to be probable.

Recovered_Sheet4

Note 2 - Basis of Presentation and Summary of Significant Accounting Policies: Research and Development Costs (Policies)	9 Months Ended
	Sep. 30, 2013
Policies	'
Research and Development Costs	'
	Research and Development Costs
	For financial reporting purposes, all costs of research and development activities performed internally or on a contract basis are expensed as incurred. For the nine months ended September 30, 2013 and 2012, research and development expenses were comprised primarily of technical consulting expenses, travel, materials and operational costs related to the development of the production line.

Recovered_Sheet5

Note 2 - Basis of Presentation and Summary of Significant Accounting Policies: Share-based Payments (Policies)	9 Months Ended
	Sep. 30, 2013
Policies	'
Share-based Payments	'
	Share-Based Payments
	We account for share-based compensation expense to reflect the fair value of share-based awards measured at the grant date.  This expense is recognized over the requisite service period and is adjusted each period for anticipated forfeitures. We estimate the fair value of each share-based award on the date of grant using the Black-Scholes option valuation model. The Black-Scholes option valuation model incorporates assumptions as to stock price volatility, the expected life of options, a risk-free interest rate and dividend yield.

Recovered_Sheet6

Note 2 - Basis of Presentation and Summary of Significant Accounting Policies: Loss Per Share (Policies)	9 Months Ended
	Sep. 30, 2013
Policies	'
Loss Per Share	'
	Loss Per Share
	We calculate basic loss per share by dividing loss available to common stockholders by the weighted-average number of shares of common stock outstanding, excluding unvested stock. Diluted loss per share is computed similar to basic loss per share except that the denominator is increased to include the number of additional shares of common stock that would have been outstanding if the potential common shares, including unvested stock, had been issued and if the additional common shares were dilutive.
	The following potentially dilutive shares of common stock are excluded from the computation of diluted net loss per share for all periods presented because the effect is anti-dilutive:
		Three months ended September 30,		Nine months ended September 30,
		2013	2012	2013	2012
	Warrants	4,122,228	1,366,108	4,122,228	1,366,108
	Convertible debt	1,152,223	374,346	1,152,223	374,346
	Stock options	571,338	591,181	571,338	591,181
	Unvested stock	275,989	168,500	275,989	168,500
	Total potentially dilutive securities	6,121,778	2,500,135	6,121,778	2,500,135

Recovered_Sheet7

Note 2 - Basis of Presentation and Summary of Significant Accounting Policies: Loss Per Share: Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Tables)	9 Months Ended
	Sep. 30, 2013
Tables/Schedules	'
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share	'
		Three months ended September 30,		Nine months ended September 30,
		2013	2012	2013	2012
	Warrants	4,122,228	1,366,108	4,122,228	1,366,108
	Convertible debt	1,152,223	374,346	1,152,223	374,346
	Stock options	571,338	591,181	571,338	591,181
	Unvested stock	275,989	168,500	275,989	168,500
	Total potentially dilutive securities	6,121,778	2,500,135	6,121,778	2,500,135

Note_5_Convertible_Debentures_

Note 5 - Convertible Debentures: Schedule of Carrying Values of Convertible Debentures (Tables)	9 Months Ended
	Sep. 30, 2013
Tables/Schedules	'
Schedule of Carrying Values of Convertible Debentures	'
		30-Sep-13	31-Dec-12
	Debentures Due June 22, 2013, in default at June 30, 2013, interest at 18%	$               1,352,975	$               4,117,750
	Debentures Due June 23, 2014, interest at 10%	2,553,000	-
	Original issue discount	-	(155,443)
		3,905,975	3,962,307
	Beneficial conversion feature and warrant allocation	-	(415,811)
	Carrying value	$               3,905,975	$               3,546,496

Note_5_Convertible_Debentures_1

Note 5 - Convertible Debentures: Schedule Of Interest Expense Convertible Debentures (Tables)	9 Months Ended
	Sep. 30, 2013
Tables/Schedules	'
Schedule Of Interest Expense Convertible Debentures	'
		Three months ended September 30,		Nine months ended September 30,
		2013	2012	2013	2012
	Amortization of original issue discount	$                    -	$                    78,588	$                  155,443	$                  229,416
	Amortization of beneficial conversion feature and warrant allocation	-	187,242	415,811	522,713
	Amortization of loan costs	-	55,515	104,392	165,337
	Penalty interest	-	-	144,121	-
	Stated interest payable in cash	124,012	-	135,294	-
		$                  124,012	$                  321,345	$                  955,061	$                  917,466

Note_7_Loans_Payable_Schedule_

Note 7 - Loans Payable: Schedule of Maturities of Long-Term Debt (Tables)	9 Months Ended
	Sep. 30, 2013
Tables/Schedules	'
Schedule of Maturities of Long-Term Debt	'
		30-Sep-13
	2013	4,005,975
		$               4,005,975

Note_8_Stockholders_Equity_Sch

Note 8 - Stockholders' Equity: Schedule of Outstanding Warrants (Tables)	9 Months Ended
	Sep. 30, 2013
Tables/Schedules	'
Schedule of Outstanding Warrants	'
			Weighted-Average
	Exercise	Warrants	Remaining Contractual	Number
	Price	Outstanding	Life (Years)	Exercisable
	$1.50	2,909,360	1.9	2,909,360
	$2.00	580,667	2.7	580,667
	$9.00	262,750	2.4	262,750
	$11.00	156,071	2.1	156,071
	$13.00	213,380	2.7	213,380
		4,122,228	2.3	4,122,228

Note_1_Business_and_Organizati1

Note 1 - Business and Organization (Details)	9 Months Ended
	Sep. 30, 2013
Details	'
Cumulative Percentage of Ownership	66.67%

Recovered_Sheet8

Note 2 - Basis of Presentation and Summary of Significant Accounting Policies: Cash and Cash Equivalents (Details) (USD $)	Sep. 30, 2013	Dec. 31, 2012
Details	'	'
Cash in excess of federal insurance limits	$0	$78,188

Recovered_Sheet9

Note 2 - Basis of Presentation and Summary of Significant Accounting Policies: Non-controlling Interest (Details)	Sep. 30, 2013
Details	'
Non-controlling Interest, Telisar Corporation	33.30%

Recovered_Sheet10

Note 2 - Basis of Presentation and Summary of Significant Accounting Policies: Loss Per Share: Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details)	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Antidilutive Securities Excluded From Computation of Earnings Per Share	6,121,778	2,500,135	6,121,778	2,500,135
Warrant	'	'	'	'
Antidilutive Securities Excluded From Computation of Earnings Per Share	4,122,228	1,366,108	4,122,228	1,366,108
Convertible Debt Securities	'	'	'	'
Antidilutive Securities Excluded From Computation of Earnings Per Share	1,152,223	374,346	1,152,223	374,346
EmployeestockoptionMember	'	'	'	'
Antidilutive Securities Excluded From Computation of Earnings Per Share	571,338	591,181	571,338	591,181
Unvested Stock	'	'	'	'
Antidilutive Securities Excluded From Computation of Earnings Per Share	275,989	168,500	275,989	168,500

Note_3_Going_Concern_Matters_D

Note 3 - Going Concern Matters (Details) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012	Dec. 31, 2012
Details	'	'	'	'	'
Net loss	($742,370)	($1,174,179)	($4,269,064)	($3,080,478)	'
Net cash flows from operating activities	'	'	-1,082,813	-1,411,630	'
Accumulated deficit	-87,675,703	'	-87,675,703	'	-83,406,639
Proceeds raised by private placement of common stock	'	'	$500,000	'	'

Note_4_Commitments_and_Conting1

Note 4 - Commitments and Contingencies (Details) (USD $)	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Dec. 18, 2012
Details	'	'	'
Operating Lease Monthly Payments	'	'	$2,035
Rent Expense	$18,542	$8,782	'

Note_5_Convertible_Debentures_2

Note 5 - Convertible Debentures (Details) (ConvertibleDebenturesMember, USD $)	9 Months Ended
	Sep. 30, 2013
ConvertibleDebenturesMember	'
Proceeds from issuance of convertible notes and warrants	$3,500,000
Debenture Issue Price Percentage	85.00%
Conversion Price per Share	$11
Limit on Beneficial Ownership as a Percentage of Outstanding Shares	4.99%
Debt Securities Default Condition Monetary Limit	$150,000
Assets Disposal Percentage	50.00%
Warrants Issued in Conjunction with Convertible Debentures	187,175
Warrants Exercise Price	$13

Note_5_Convertible_Debentures_3

Note 5 - Convertible Debentures: Schedule of Carrying Values of Convertible Debentures (Details) (USD $)	Sep. 30, 2013		Dec. 31, 2012
Original issue discount	'		($155,443)
Issue price	3,905,975		3,962,307
Beneficial conversion feature and warrant allocation	'		-415,811
Carrying value	3,905,975		3,546,496
Debentures due June 22, 2013	'		'
Face amount	1,352,975	[1]	4,117,750	[1]
Debentures due June 23, 2014	'		'
Face amount	$2,553,000	[1],[2]	'
[1]	Interest at 18%
[2]	Interest at 10%

Note_5_Convertible_Debentures_4

Note 5 - Convertible Debentures: Schedule Of Interest Expense Convertible Debentures (Details) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Details	'	'	'	'
Amortization of original issue discount	'	$78,588	$155,443	$229,416
Amortization of beneficial conversion feature and warrant allocation	'	187,242	415,811	522,713
Amortization of loan costs	'	55,515	104,392	165,337
Interest Expense Related to Convertible Debentures	'	'	144,121	'
Stated interest payable in cash	124,012	'	135,294	'
Interest expense related to the convertible debentures	$124,012	$321,345	$955,061	$917,466

Note_6_Convertible_Bridge_Loan1

Note 6 - Convertible Bridge Loans (Details) (USD $)	3 Months Ended		9 Months Ended
	Mar. 31, 2013	Dec. 31, 2011	Sep. 30, 2013	Sep. 30, 2012	Nov. 30, 2011
Loss recognized on conversion of debt	'	'	$1,085,744	'	'
Mark W Weber	'	'	'	'	'
Proceeds from issuance of convertible notes and warrants	'	50,000	'	'	'
ConvertibleBridgeLoans1Member	'	'	'	'	'
Proceeds from issuance of convertible notes and warrants	'	475,000	'	'	'
Debt Instrument, Interest Rate, Effective Percentage	'	'	'	'	12.00%
Interest Expense, Debt	'	'	7,027	42,760	'
Debt Instrument, Convertible, Conversion Price	$11	'	$11	'	'
Debt Conversion, Converted Instrument, Amount	368,162	'	'	'	'
Accrued Interest and Loan Fees Included in Conversion	68,162	'	'	'	'
Bridge Loan Converted Into Shares Of Restricted Common Stock	368,162	'	368,162	'	'
Debt Conversion Converted Instrument To Warrants	368,162	'	'	'	'
Exercise Price, Warrants	1.5	'	'	'	'
Debt Conversion Converted Instrument Units Issued Two	98,571	'	98,571	'	'
Fair Value of Common Stock	662,690	'	'	'	'
Fair Value of Three Year Warrants, One	633,121	'	'	'	'
FairValueOfThreeYearWarrantsTwo	$158,094	'	'	'	'
Expected life (years)	'	'	'3 years	'	'
Risk-free interest rate	'	'	0.82%	'	'
Estimated volatility	'	'	227.10%	'	'
Expected Dividend Rate	'	'	0.00%	'	'
Rate Increase	'	'	'	'	'
Debt Instrument, Interest Rate, Effective Percentage	'	'	'	'	15.00%

Note_7_Loans_Payable_December_

Note 7 - Loans Payable: December 20, 2012 (Details) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012	Dec. 20, 2012
Amortization of prepaid interest	$27,600	$0	$25,000	$0	'
Amortization of loan costs	'	'	118,500	165,337	'
Interest expense	151,612	334,495	1,040,311	960,226	'
December 20, 2012 Loan Payable	'	'	'	'	'
Proceeds From Loan Agreement	'	'	'	'	100,000
Amortization of prepaid interest	'	'	25,000	'	'
Amortization of loan costs	'	'	15,000	'	'
Interest expense	$27,600	$0	$54,114	$0	'
Default Interest rate	'	'	109.50%	'	'

Note_7_Loans_Payable_Schedule_1

Note 7 - Loans Payable: Schedule of Maturities of Long-Term Debt (Details) (USD $)	Sep. 30, 2013
Details	'
Convertible Debentures and Loan Payable	$4,005,975
Total convertible bridge loans	$4,005,975

Note_7_Loans_Payable_May_16_20

Note 7 - Loans Payable: May 16, 2013 (Details) (USD $)	3 Months Ended		9 Months Ended				9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	16-May-13	Sep. 30, 2013
					May 16, 2013 Loan Payable	May 16, 2013 Loan Payable	ConvertibleDebenturesMember
Proceeds From Loan Agreement	'	'	'	'	'	$100,000	'
Interest expense	151,612	334,495	1,040,311	960,226	10,000	'	'
Converted Loan Amount	'	'	110,000	'	'	'	'
Converted Loan Conversion Price	'	'	$1.50	'	'	'	'
Shares issued for converted loan	'	'	73,333	'	'	'	'
Exercise Price	'	'	$2	'	'	'	'
Fair Value Common Stock	'	'	95,333	'	'	'	'
Market Price	'	'	$1.30	'	'	'	'
Fair Value Warrants	'	'	43,687	'	'	'	'
Loss on conversion of debt	'	$60,774	$1,114,764	$353,161	'	'	$29,020

Note_7_Loans_Payable_Details

Note 7 - Loans Payable (Details) (Warrants1Member)	9 Months Ended
	Sep. 30, 2013
Warrants1Member	'
Expected life (years)	'3 years
Risk-free interest rate	0.42%
Estimated volatility	91.40%
Expected Dividend Rate	0.00%

Note_8_Stockholders_Equity_Det

Note 8 - Stockholders' Equity (Details)	Sep. 30, 2013	Dec. 31, 2012	Aug. 26, 2013
			2007 Stock Incentive Plan
Preferred stock shares authorized	10,000,000	10,000,000	'
Common stock shares authorized	90,000,000	90,000,000	2,500,000

Note_8_Stockholders_Equity_201

Note 8 - Stockholders' Equity: 2012 Unit Offering Amendment (Details) (USD $)	9 Months Ended	3 Months Ended	6 Months Ended	12 Months Ended
	Sep. 30, 2013	Mar. 31, 2013	Jun. 30, 2013	Dec. 31, 2012
		2012 Unit Offering	2012 Unit Offering	2012 Unit Offering
Issuance Of Restricted Common Stock	'	'	'	474,632
Issuance Of Three Year Warrants	'	'	'	474,632
Exercise Price	$2	'	'	$2
Private Placement To Accredited Investors	'	'	'	$3.50
Purchase Price	'	$1	'	'
Warrant Exercise Price	'	$1.50	$1.50	'
Issuance Of Additional Shares Of Common Stock To Investors	'	1,186,567	1,186,567	'
Issuance Of Additional Shares Reserved For Exercise Of Warrants	'	1,186,567	'	'
Net Proceeds Of Warrants And Common Stock	'	$1,425,768	'	'
Proceeds Allocated To Warrants	'	587,989	'	'
Proceeds Allocated To Common Stock	'	$837,779	'	'

Note_8_Stockholders_Equity_2011

Note 8 - Stockholders' Equity: 2013 Unit Offering (Details) (USD $)	9 Months Ended	3 Months Ended
	Sep. 30, 2013	Mar. 31, 2013	Mar. 31, 2013
		2013 Unit Offering	CommonStockAndWarrantsMember
Restricted Shares To Accredited Investors	'	105,000	'
Purchase Price	'	$1	'
Proceeds From Restricted Shares To Accredited Investors	'	$105,000	'
Issuance Of Three Year Warrants	'	105,000	'
Warrant Exercise Price	'	$1.50	'
Proceeds Allocated To Warrants	'	52,363	'
Proceeds Allocated To Common Stock	'	52,637	'
Expected life (years)	'	'3 years	'3 years
Risk-free interest rate	'	0.42%	0.34%
Estimated volatility	'	346.40%	91.40%
Expected Dividend Rate	'	0.00%	0.00%
Proceeds raised from accredited investors	871,000	'	'
Converted Loan Conversion Price	$1.50	'	'
Converted Loan Amount	110,000	'	'
Proceeds from board of directors	10,000	'	'
Aggregate shares issued	580,667	'	'
Exercise Price	$2	'	'
Net proceeds raised	761,000	'	'
Fair Value Allocated to warrants	256,836	'	'
Fair Value Allocated to common stock	$504,164	'	'

Note_8_Stockholders_Equity_Iss

Note 8 - Stockholders' Equity: Issuances of common stock (Details) (USD $)	3 Months Ended	9 Months Ended
	Mar. 31, 2013	Sep. 30, 2013
Shares Issued in Unit Offering	'	685,667
Sam Advisors	'	'
Issuance of Common Shares	'	48,842
Common Stock Fair Value	'	75,000
Converted Consulting Fees	'	12,500
Charles Hunt	'	'
Common Stock Fair Value	'	11,250
Converted Consulting Fees	'	3,750
ConvertibleBridgeLoans1Member	'	'
Bridge Loan Converted Into Shares Of Restricted Common Stock	368,162	368,162

Note_8_Stockholders_Equity_Sto

Note 8 - Stockholders' Equity: Stock Issuances (Details) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012	Jun. 30, 2014	Dec. 31, 2013	Aug. 26, 2013	Jun. 15, 2013	Jun. 30, 2013	Feb. 20, 2013
									Stock and Options 2007 Stock Incentive Plan	Stock and Options 2007 Stock Incentive Plan
Restricted Shares Granted	'	'	'	'	'	'	'	'	'	80,000
Restricted Shares Granted, Fair Value	'	'	'	'	'	'	'	'	'	$128,800
Closing Market Price, Restricted Shares Fair Value	'	'	'	'	'	'	'	'	$1.61	$1.61
Restricted stock issued for consulting services	'	'	'	'	'	'	'	19,231	'	'
Fair value restricted stock issued for consulting services	'	'	'	'	'	'	'	25,000	'	'
Closing market price	'	'	'	'	'	'	$1.20	$1.30	'	'
Restricted stock issued for services	'	'	'	'	'	'	300,000	'	'	'
Fair value restricted stock issued for services	'	'	'	'	'	'	360,000	'	'	'
Stock Issuance Compensation Expense	57,302	132,665	419,617	172,780	'	'	'	'	'	'
Unvested Restricted Shares	275,989	'	275,989	'	'	'	'	'	'	'
Unvested Restricted Shares Unrecognized Compensation Cost	$332,547	'	$332,547	'	$207,587	$124,960	'	'	'	'

Note_8_Stockholders_Equity_Sto1

Note 8 - Stockholders' Equity: Stock Option issuances (Details) (USD $)	3 Months Ended		9 Months Ended		12 Months Ended		6 Months Ended		6 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012	Dec. 31, 2014	Dec. 31, 2013	Jun. 30, 2013	Feb. 20, 2013	Jun. 30, 2013	Mar. 11, 2013
							Board Members And Officer	Board Members And Officer	William B. Smith	William B. Smith
Issuance Of Stock Options	'	'	'	'	'	'	'	42,600	'	250,000
Exercise Price	'	'	$2	'	'	'	$1.61	'	$1.70	'
Fair Value Of Stock Options Issued	'	'	'	'	'	'	$68,741	'	$410,540	'
Expected life (years)	'	'	'	'	'	'	'10 years	'	'5 years	'
Risk-free interest rate	'	'	'	'	'	'	2.02%	'	0.90%	'
Estimated volatility	'	'	'	'	'	'	246.20%	'	188.80%	'
Expected Dividend Rate	'	'	'	'	'	'	0.00%	'	0.00%	'
Compensation Expense Of Stock Options	87,429	1,933	422,062	132,416	'	'	'	'	'	'
Unrecognized Compensation Expense Related To Stock Options	'	'	60,935	'	'	'	'	'	'	'
Unrecognized Compensation Expense Related To Stock Options To Be Recognized	'	'	'	'	$26,724	$34,212	'	'	'	'
Expired options to purchase common stock	'	'	30,266	'	'	'	'	'	'	'
Weighted average exercise price	'	'	$14.32	'	'	'	'	'	'	'

Note_8_Stockholders_Equity_War

Note 8 - Stockholders' Equity: Warrants (Details) (USD $)	9 Months Ended	3 Months Ended	6 Months Ended	3 Months Ended	9 Months Ended
	Sep. 30, 2013	Mar. 31, 2013	Jun. 30, 2013	Mar. 31, 2013	Sep. 30, 2013
		2012 Unit Offering	2012 Unit Offering	ConvertibleBridgeLoans1Member	ConvertibleBridgeLoans1Member
Issuance Of Additional Shares Of Common Stock To Investors	'	1,186,567	1,186,567	'	'
Warrant Exercise Price	'	$1.50	$1.50	'	'
Warrants Issued in Unit Offering	105,000	'	'	'	'
Warrants issued to purchase common shares	580,667	'	'	'	'
Warrants issued to purchase common shares exercise price	$2	'	'	'	'
Common shares issued	368,162	'	'	'	'
Debt Conversion Converted Instrument Units Issued Two	'	'	'	98,571	98,571
Debt Instrument, Convertible, Conversion Price	'	'	'	$11	$11
Warrants Expired	230,858	'	'	'	'
Exercise Price of Warrants Expired	15.31	'	'	'	'

Note_8_Stockholders_Equity_Sch1

Note 8 - Stockholders' Equity: Schedule of Outstanding Warrants (Details)	Sep. 30, 2013
Warrant One	'
Exercise Price, Warrants	1.5
Warrants Outstanding	2,909,360
Weighted - Average Remaining Contractual Life (Years)	1.9
Warrants Exercisable	2,909,360
Warrant Two	'
Exercise Price, Warrants	2
Warrants Outstanding	580,667
Weighted - Average Remaining Contractual Life (Years)	2.7
Warrants Exercisable	580,667
Warrant Three	'
Exercise Price, Warrants	9
Warrants Outstanding	262,750
Weighted - Average Remaining Contractual Life (Years)	2.4
Warrants Exercisable	262,750
Warrant Four	'
Exercise Price, Warrants	11
Warrants Outstanding	156,071
Weighted - Average Remaining Contractual Life (Years)	2.1
Warrants Exercisable	156,071
Warrant Five	'
Exercise Price, Warrants	13
Warrants Outstanding	213,380
Weighted - Average Remaining Contractual Life (Years)	2.7
Warrants Exercisable	213,380
Warrant	'
Warrants Outstanding	4,122,228
Weighted - Average Remaining Contractual Life (Years)	2.3
Warrants Exercisable	4,122,228

Note_9_Related_Party_Transacti1

Note 9 - Related Party Transactions (Details) (USD $)	9 Months Ended
	Sep. 30, 2013
Sam Advisors	'
Issuance of Common Shares	48,842
Common Stock Fair Value	$75,000
Converted Consulting Fees	12,500
Charles Hunt	'
Common Stock Fair Value	11,250
Converted Consulting Fees	$3,750

Note_10_Subsequent_Events_Deta

Note 10 - Subsequent Events (Details) (USD $)	9 Months Ended
	Sep. 30, 2013
Proceeds raised by private placement of common stock	$500,000
Proceeds raised by private placement of common stock price per share	$1
Exercise Price	$2
Subsquent Events	'
Issuance of Common Shares	500,000
Exercise Price	$1.25